Endocrine Diseases

Citations 101-110 of 405 total displayed.

Past content (since Jul 1998):

Letters
Pioglitazone vs Glimepiride in the PERISCOPE Trial—Reply

Steven E. Nissen; Stephen J. Nicholls; Kathy Wolski
JAMA 2008; 300: 788. [Extract] [Full text] [PDF]  

Letters
Insulin Therapy and Lipid Overload in Type 2 Diabetes

Raffaele Marfella; Michelangela Barbieri; Giuseppe Paolisso
JAMA 2008; 300: 789. [Extract] [Full text] [PDF]  

Letters
Insulin Therapy and Lipid Overload in Type 2 Diabetes—Reply

Roger H. Unger
JAMA 2008; 300: 790. [Extract] [Full text] [PDF]  

Preliminary Communications
Arsenic Exposure and Prevalence of Type 2 Diabetes in US Adults

Ana Navas-Acien; Ellen K. Silbergeld; Roberto Pastor-Barriuso; Eliseo Guallar
JAMA 2008; 300: 814-822. [Abstract] [Full text] [PDF]  

Editorials
Environmental Arsenic Exposure and Diabetes

Molly L. Kile; David C. Christiani
JAMA 2008; 300: 845-846. [Extract] [Full text] [PDF]  

Health Agencies Update
Drugs and Cancer Risk

Bridget M. Kuehn
JAMA 2008; 300: 386-c. [Extract] [Full text] [PDF]  

Health Agencies Update
Pesticides-Diabetes Link

Bridget M. Kuehn
JAMA 2008; 300: 386-a. [Extract] [Full text] [PDF]  

Letters
Oral Hypoglycemic Use and the SANDS Trial—Reply

Barbara V. Howard; William James Howard; Robert E. Ratner
JAMA 2008; 300: 389-a-390-a. [Extract] [Full text] [PDF]  

Letters
Oral Hypoglycemic Use and the SANDS Trial

Eva L. Evans; Rohit P. Ojha; Lori A. Fischbach
JAMA 2008; 300: 389. [Extract] [Full text] [PDF]  

Commentaries
Heart Failure With Preserved Ejection Fraction: Treat Now by Treating Comorbidities

Sanjiv J. Shah; Mihai Gheorghiade
JAMA 2008; 300: 431-433. [Extract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41